window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

AI drug discovery

  • Artificial Intelligence,Biotech,Drug Development,Drug discovery,Research & Development

    ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board

    ProQR Therapeutics has entered a collaboration with Ginkgo Bioworks to [...]

    April 9, 2026
  • Artificial Intelligence,Drug Development,Drug discovery,Research & Development,Technology and platforms

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    A new analyst report from William Blair has highlighted Carterra [...]

    April 9, 2026
  • Artificial Intelligence,Clinical studies,Drug discovery,Neurosciences,Pharmaceuticals and therapeutics

    AI-derived drug candidate reduces fentanyl intake in preclinical opioid study

    A study published in Proceedings of the National Academy of [...]

    April 8, 2026
  • Artificial Intelligence,Drug discovery,Partnerships & Funding

    Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly

    Insilico Medicine has signed a drug discovery collaboration with Eli [...]

    March 31, 2026
  • Artificial Intelligence,Digital Health,Mental health,Neurosciences,Research & Development

    Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder

    BullFrog AI Holdings has entered a commercial agreement with a [...]

    March 30, 2026
  • Artificial Intelligence,Drug discovery,Neurosciences,Partnerships & Funding

    insitro and Bristol Myers Squibb expand ALS targets in AI collaboration

    insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

    March 23, 2026
  • Artificial Intelligence,Oncology

    Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies

    Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

    March 3, 2026
  • Artificial Intelligence,Biotech,Drug discovery,Oncology,Partnerships & Funding,Research & Development,Technology and platforms

    Evogene partners QUT on AI drug discovery for lung cancer resistance

    Evogene Ltd has partnered with Queensland University of Technology to [...]

    February 19, 2026
  • Artificial Intelligence,Biotech,Drug Development,Partnerships & Funding,Research & Development,Technology and platforms

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    Nuclera and leadXpro have entered a scientific partnership to develop [...]

    February 17, 2026
  • Artificial Intelligence,Biotech,Central Nervous System,Clinical Development,Drug Development,Immunology,Pharmaceuticals and therapeutics,Technology and platforms

    Insilico Medicine and CMS announce AI-powered drug discovery collaborations in CNS and autoimmune diseases

    Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

    February 15, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Genmab appoints Margarida Duarte as general manager for Europe and emerging markets
    Categories: Healthcare leadership, Mergers & Acquisitions, Movers & Shakers, Pharmaceuticals and therapeutics
  • Opella appoints former Reckitt executive Gonzalo Balcazar to lead Europe and Latin America
    Categories: Healthcare leadership, Market Access & Commercialization, Movers & Shakers, Pharmaceuticals and therapeutics, Startups and innovations
  • Orano Med appoints Frederic Desdouits as CEO to advance targeted alpha therapy pipeline
    Categories: Biotech, Healthcare leadership, Movers & Shakers, Oncology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top